Some of the potential medicines coming down the pipeline include: Survodutide , mazdutide , and pemvidutide , weekly injectable drugs that work on both GLP-1 and glucagon receptors to help reduce weight and lower blood sugar Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon that comes in a once-weekly injection Pramlintide and cagrilintide, injectable drugs that work by acting on receptors for amylin, a hormone produced by the pancreas that plays a role in blood sugar control and satiety (fullness) How long will I take weight loss medications
Why is the Retatrutide a solid puck and not a loose powder
The patient-friendly bottom line Many people can use GLP-1 drugs safely
It remains under clinical investigation and has not received marketing authorisation, meaning it cannot be prescribed as a standard weight management medicine
It has been reported histone lactylation, especially H3K18la, can promote gene transcription including numerous pro-fibrotic genes [17, 29, 32]
Bloating and sulfur burps share the same root cause: excess gas from fermentation